Overview

Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (The IMPERIAL Study)

Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of OC-01 Nasal Spray as compared to placebo in simulating Goblet Cell and Meibomian Gland function in adult subjects with DED.
Phase:
Phase 2
Details
Lead Sponsor:
Oyster Point Pharma, Inc.